News › Diversified  ·  2 May 2026, 8:58 AM IST  ·  4 months ago

Bullish Signal: Sumeet Bagadia Recommends RELIANCE, KOTAKBANK

VolatileBias: Bullish +5790% confidenceDiversifiedBankingBullish read

In one line — For KOTAKBANK, traders should assess if the analyst's positive view can counter recent sector weakness, focusing on entry points with tight risk management.

Bearish
Bullish
−1000+57+100

Source: Mint · AI-summarised by Anadi · Updated 2 May 2026, 9:41 AM IST

Diversifiedtilt positive
Bankingtilt positive
Pharmaceuticalstilt positive

What Happened

Sumeet Bagadia, a well-known market analyst, has issued 'buy' recommendations for three major Indian stocks: Reliance Industries, Kotak Mahindra Bank, and Sun Pharmaceutical Industries, ahead of Monday's trading session. This guidance is fresh and directly actionable for short-term traders.

Why It Matters (for you)

Analyst recommendations, especially from recognized experts, can influence retail and institutional investor sentiment, leading to increased buying interest and potential price movements. For the Indian market, such calls on large-cap stocks can contribute to overall market momentum or sector-specific rallies.

Impact on Indian Markets

RELIANCE, KOTAKBANK, and SUNPHARMA are likely to see increased trading volumes and potential upward price movement at market open on Monday due to these positive recommendations. The banking sector, represented by KOTAKBANK, could also see a positive spillover, although recent news (Context [5]) indicates some banking stocks have faced pressure.

What Traders Should Watch Next

Traders should monitor the opening price action and volume for these three stocks on Monday. Look for confirmation of buying interest and consider setting appropriate risk control levels. Also, observe broader market sentiment and any new developments in the banking and pharma sectors.

Key Evidence

  • Sumeet Bagadia recommends three stocks to buy on Monday, May 4, 2026.
  • The recommended stocks are Reliance, Kotak Mahindra Bank, and Sun Pharma.
  • Risk flag: Broader market weakness could negate individual stock recommendations.
  • Risk flag: Any negative news specific to Reliance, Kotak Mahindra Bank, or Sun Pharma could override the analyst's call.
  • Risk flag: Profit booking after an initial surge could occur.